Medherant

Coventry, United Kingdom

Medherant is developing a first-in-class transdermal drug delivery patch for prescription and OTC medicines.

$3.6M raised

Apr 2023

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Medherant raised?

Medherant has raised $3.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2023.

Who are Medherant's investors?

Medherant's investors include Innovate UK, Mercia Asset Management.

Where is Medherant headquartered?

Medherant is headquartered in Coventry, United Kingdom.

What does Medherant do?

Medherant is developing a first-in-class transdermal drug delivery patch for prescription and OTC medicines.

What stage is Medherant at?

Medherant is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 3, 2023.

MLA

"Medherant — Funding & Investors." VCBacked, April 3, 2023, https://www.vcbacked.co/company/medherant. Accessed July 2, 2026.

APA

VCBacked. (2023). Medherant — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/medherant

Wikipedia (cite web)

{{cite web |title=Medherant — Funding & Investors |url=https://www.vcbacked.co/company/medherant |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 3, 2023.